Synthetic THC And Blood Pressure
NCT07231965 · Status: NOT_YET_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-05-07
Summary
To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology
Conditions
- Blood Pressure
Interventions
- DRUG
-
Dronabinol
Patients will take one 10 mg dose of Dronabinol.
- DRUG
-
Patients will take one 10mg dose of a Placebo Pill.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Virend Somers · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-31
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation
NCT01798186 ·Status: COMPLETED ·Phase: PHASE1
-
L-citrulline Supplementation, Cold Exposure, & Post-Exercise Muscle Ischemia
NCT02104375 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers
NCT04461756 ·Status: COMPLETED ·Phase: PHASE1
-
Nutritional Supplements and Nitric Oxide Bioactivity
NCT03625596 ·Status: COMPLETED ·Phase: NA
-
Breath Metabolomics of Placebo Effects, a Pilot Study
NCT04956718 ·Status: COMPLETED ·Phase: NA
-
Response to Clenbuterol in Humans
NCT03860870 ·Status: COMPLETED ·Phase: NA
-
The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol
NCT05742724 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
NCT03738943 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Beta2-adrenergic Agonism and Muscle Remodelling
NCT03565302 ·Status: UNKNOWN ·Phase: NA
-
Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions
NCT01448772 ·Status: COMPLETED ·Phase: PHASE1
-
Modulation of Metabolic Rate by Inorganic Nitrate
NCT02022176 ·Status: COMPLETED ·Phase: NA
-
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis
NCT01137656 ·Status: COMPLETED ·Phase: PHASE1
-
Salmeterol Effect on Exercise Performance
NCT06655012 ·Status: RECRUITING ·Phase: NA
-
Pharmacokinetics of the Basel Phenotyping Cocktail Combination Capsule
NCT03247699 ·Status: COMPLETED ·Phase: NA
-
Salbutamol, Pharmacogenetics and Breathing Mechanics
NCT01903785 ·Status: COMPLETED ·Phase: PHASE4
-
Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions
NCT01380457 ·Status: COMPLETED ·Phase: PHASE1
-
Methemoglobin Concentration in High Dose Inhaled Nitric Oxide
NCT05612074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Dopamine and Muscle Function in the Heat
NCT03515668 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of DMT in Healthy Adults
NCT05573568 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study to Determine the Metabolism and Clearance of Baxdrostat
NCT05961384 ·Status: COMPLETED ·Phase: PHASE1
-
Contribution of L-Tyrosine to Recovery From Operational Strain on Return From External Operation
NCT04549194 ·Status: COMPLETED ·Phase: NA
-
¹³C-Methacetin Breath Test (MBT) Methodology Study
NCT01205074 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Thebaine Urine Testing
NCT07192887 ·Status: RECRUITING
-
Dietary Nitrate and Cardiovascular Health
NCT01262521 ·Status: COMPLETED ·Phase: NA
-
Influence of Bedrest and Hypocaloric Nutrition on Endothelium-Dependent Vasoreactivity
NCT00175968 ·Status: COMPLETED ·Phase: PHASE1